VUNO Showcases DeepCARS® at AACN NTI 2025, Highlighting AI-Driven Cardiac Arrest Risk Prediction
– Company engages U.S. critical care professionals with data-driven early warning solution MARLBOROUGH, Mass., May 26, 2025 /PRNewswire/ -- VUNO,...
Staff
Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025)
– Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of lorundrostat in over 1,000 participants...
ZLNA – Issuance of shares through set-off of option exercise fee
Oslo, 24 May 2025: Zelluna ASA (the "Company") refers to the resolution by the Company's Annual General Meeting held on...
BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain.
Los Angeles, CA and Vancouver, BC, May 23, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the...
IMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of...
INDY 500 Stars Join Forces with ZERO Prostate Cancer to Put Veterans’ Health in the Spotlight at Memorial Day Weekend Races
INDIANAPOLIS, May 23, 2025 /PRNewswire/ -- This Memorial Day Weekend, the spotlight won't only be on speed—it'll be on saving lives....
Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering
IRVING, Texas, May 23, 2025 /PRNewswire/ -- Caris Life Sciences® ("Caris"), a leading, patient-centric, next-generation AI TechBio company and precision medicine...
Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
PLEASANTON, Calif., May 23, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE)(the "Company") announced today that it received a notice (the...
Yardi Expert David Bellew elected to Argentum Board of Directors
Senior director of Senior Living Suite joins board of national senior living industry association SANTA BARBARA, Calif., May 23, 2025...
Evidently Hires Andrés Krogh-Walker as Head of Marketing
The clinical data intelligence platform continues executive team expansion following $15 million funding round PALO ALTO, Calif.--(BUSINESS WIRE)--#AI--Clinical data intelligence...
Quantum Sensors Market to Hit USD 839 Million by 2031 | Key Growth in Defense, Healthcare & IT – Valuates Reports
BANGALORE, India, May 23, 2025 /PRNewswire/ -- Quantum Sensors Market is Segmented by Type (Atomic Clock, Gravity Sensor, Magnetic Sensor,...
RED DOOR COMMUNITY LAUNCHES NEW “COMMUNITY CONNECTIONS” BLOG AS A RESOURCE FOR THOSE IMPACTED BY CANCER
This new platform offers an opportunity to share expert insights, common experiences, and inspirations as we explore the realities of...
AI Could Add $461 Billion to Global Healthcare–And These New Platforms Are Leading the Charge
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 23, 2025 /PRNewswire/ -- Equity Insider...
Perrigo to Attend the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference
DUBLIN, May 23, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced...
O’Shaughnessy Ventures Backs AI-Powered Dream Reconstruction
Ninon Lizé Masclef awarded $100,000 fellowship to turn brain-wave data into 3D visualizations of dreams GREENWICH, Conn., May 23, 2025 /PRNewswire/...
Bulletin from the annual general meeting in Truecaller AB on 23 May 2025
STOCKHOLM, May 23, 2025 /PRNewswire/ -- Today, on 23 May 2025, the annual general meeting was held in Truecaller AB. A...
CHMP recommends EU approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer
Positive recommendation based on phase III INAVO120 data showing ItovebiTM (inavolisib) in combination with palbociclib and fulvestrant more than doubled...
Syncromune® Inc. Announces Publication of Abstract on SYNC-T® Therapy SV-102 Phase 1 Data for Metastatic Prostate Cancer at ASCO 2025 Annual Meeting
Study Demonstrated 87% Overall Response Rate in Metastatic Prostate Cancer Patients Treated with SYNC-T, a First-in-Class In Situ Personalized Immunotherapy...
Think Together Expands Executive Team with Matt Scharpnick as Chief of Innovation
Think Together creates new C-suite role to fuel market innovation and transform educational outcomes as it expands services and impact...
MindHYVE.ai™ and Islamabad Diagnostic Centre Forge Strategic Alliance to Launch AGI-Powered Diagnostic Intelligence Across Pakistan
ISLAMABAD, May 22, 2025 /PRNewswire/ -- In a groundbreaking move to elevate clinical diagnostics nationwide, MindHYVE.ai™, a U.S.-based pioneer in...